Endothelial Phenotype Evoked by Low Dose Carvedilol in Pulmonary Hypertension

Endothelial Phenotype Evoked by Low Dose Carvedilol in Pulmonary Hypertension

Background: The therapeutic benefits of β-blockers are well established in left heart failure. The Pulmonary Arterial Hypertension Treatment with Carvedilol for Heart Failure [PAHTCH] study showed safety and possible benefit of carvedilol in pulmonary arterial hypertension (PAH) associated right hea...

Full description

Bibliographic Details
Main Authors: Hoi I Cheong, Samar Farha, Margaret M. Park, James D. Thomas, Didem Saygin, Suzy A. A. Comhair, Jacqueline Sharp, Kristin B. Highland, W. H. Wilson Tang, Serpil C. Erzurum
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
pulmonary hypertension
carvedilol
β-blockers
nitric oxide
right ventricle
Online Access:https://www.frontiersin.org/article/10.3389/fcvm.2018.00180/full

Internet

https://www.frontiersin.org/article/10.3389/fcvm.2018.00180/full

Similar Items